albutrepenonacog alfa
Recombinant proteinexperimental
Factor IX, also known as Christmas factor, is one of the serine proteases involved in coagulation; it belongs to peptidase family S1. Deficiency of this protein causes haemophilia B. — Wikipedia
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
3
Phase 4
1
Earliest trial started Feb 1, 2012 (NCT01496274)
Timeline
Indications
Approved for
Studied for
Mechanism of action
- Coagulation factor IXEXOGENOUS PROTEIN
Coagulation factor IX exogenous protein
Recombinant coagulation factor IX fused to albumin
- Coagulation factor IXSupplementation
F9 supplementation
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaFactor IX ↗
- NCATSA57KX1VL5P ↗
- ChEMBLCHEMBL5315076 ↗
Also known as
- albutrepenonacog alfa
- rix-fp
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04108260 | Phase 4 | Nov 30, 2019 | National Taiwan University |
| NCT02053792 | Phase 3 | Feb 1, 2014 | CSL Behring |
| NCT01662531 | Phase 3 | Jan 1, 2013 | CSL Behring |
| NCT01496274 | Phase 2/Phase 3 (Phase 3) | Feb 1, 2012 | CSL Behring |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CSL Behring | For profit | 3 | 3 | 1 | 2012 |
| National Taiwan University | Academic/Hospital | 1 | 1 | 1 | 2019 |
2 organizations
Page 1 / 1